Subscribe
shutterstock_621316742_tero_vesalainen
Tero Vesalainen / Shutterstock.com
24 March 2022GenericsAlex Baldwin

Campaigners ask US govt to force down prices for common drugs

Entities backing the Make Meds Affordable campaign have asked US health authorities President Biden to end “patent monopolies” on six common medicines to bring down prices.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Clarivate’s ‘drugs to watch’ list signals high prices to come
11 February 2020   Clarivate Analytics has released its annual “drug to watch” list, compiled through its Cortellis database of life sciences-focused research and development data.
Americas
Mexican Senate launches bill to modify patented drug prices
21 February 2019   The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
Clarivate’s ‘drugs to watch’ list signals high prices to come
11 February 2020   Clarivate Analytics has released its annual “drug to watch” list, compiled through its Cortellis database of life sciences-focused research and development data.
Americas
Mexican Senate launches bill to modify patented drug prices
21 February 2019   The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies.

More on this story

Big Pharma
Clarivate’s ‘drugs to watch’ list signals high prices to come
11 February 2020   Clarivate Analytics has released its annual “drug to watch” list, compiled through its Cortellis database of life sciences-focused research and development data.
Americas
Mexican Senate launches bill to modify patented drug prices
21 February 2019   The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB